AkesoBio Investigative Site 3003

Sydney, New South Wales 2145

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis — Stopped early